University Medicine Göttingen

What University Medicine Göttingen does

Universitätsmedizin Göttingen (UMG) is a public university medical center in Göttingen, Lower Saxony, Germany, operating under the governance of Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts. Founded in 1732, UMG is the largest employer in southern Lower Saxony with approximately 7,900 staff, 1,600 beds across 61 clinics, institutes, and departments, and an annual patient volume of 55,000 inpatients and 270,000 outpatients. The institution operates as an integrated academic medical center combining three core missions — research, teaching, and patient care — and has added Transfer as a fourth strategic pillar under its UMGestalten 2032 strategy. Research focus areas include molecular cell biology, neuroscience, cardiovascular medicine, and oncology, with active collaborations including joint development of expansion microscopy with MIT (announced 2026-06-23) and a Phase I MVA-MERS-S vaccine trial with DZIF and CEPI (published in Nature Communications, 2026-01-26).

The technical platform spans clinical care, research infrastructure, and education. Notable proprietary capabilities include a privacy-preserving federated learning framework using pre-trained CT foundation models for multi-center lymph node metastasis detection in pancreatic cancer (2026-04-09), and the STÄPS simulation training center for medical education using standardized patients and OSCE examinations. The Studienzentrum provides IT, biometry, project management, and vigilance services to support clinical trials. Revenue is generated primarily through inpatient and outpatient care billed under the German DRG (Diagnosis Related Groups) system and statutory health insurance (GKV) frameworks, supplemented by research grants (Drittmittel), state subsidies, and teaching block funding. The go-to-market is direct-to-patient, with a recently formalized 'Ärzte & Zuweiser' (referring physicians) channel and regional patient transfer services. A major Neubau (new construction) project is currently underway as part of the UMGestalten 2032 modernization initiative, and the institution hosts the iSLS 2027 international conference.

Name

University Medicine Göttingen

Legal name

Universitätsmedizin Göttingen

Website

https://umg.eu

Company type

Private

Founded year

1732

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Universitätsmedizin Göttingen is a public university medical center combining patient care, biomedical research, and medical education across 61 clinics with 1,600 beds, serving 325,000 inpatients and outpatients annually in southern Lower Saxony, Germany.

Ownership category

akta.pro rank

Product category

University Hospital and Academic Medical Center

NAICS

General Medical and Surgical Hospitals (6221), Offices of Physicians (62111)

SIC

Services-Hospitals (8060), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Ambulatory Specialty Clinics (Multi-Specialty & Single-Specialty) (HLAFABAA)

akta.pro secondary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• University medical center
• Inpatient healthcare services
• Medical research
• Clinical trials
• Medical education training

Headquarters

HQ city

Göttingen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain

Revenue model

1. Hospital Services Revenue: University medical center providing comprehensive healthcare services to patients, funded through statutory health insurance (GKV) and private insurance systems in Germany. Revenue generated from inpatient and outpatient medical treatments, procedures, and specialized clinical services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Universitätsmedizin Göttingen (UMG) operates as an academic medical center combining inpatient and outpatient clinical care, biomedical research, and medical education under a single institution. It runs 61 clinics, institutes, and departments with 1,600 beds, treating approximately 55,000 inpatients and 270,000 outpatients annually. Core clinical offerings include specialized treatments across oncology, cardiovascular medicine, neurosciences, and molecular cell biology, complemented by research focus areas and the STÄPS simulation-based medical training facility.

Product overview

The Universitätsmedizin Göttingen (UMG) operates as an academic medical center combining clinical healthcare services, medical research, and education under one institution. The organization encompasses approximately 61 clinics, institutes, and departments with 1,600 beds, serving 55,000 inpatients and 270,000 outpatients annually. Key operational units include research focus areas (Molecular Cell Biology, Neuroscience, Cardiovascular Medicine, Oncology), a Studienzentrum (Study Center) providing IT, biometry, project management and vigilance services, and STÄPS as a dedicated simulation-based medical training facility.

Differentiator

Problem solved

Functional benefit

Brands

• Medizincampus Wolfsburg (MCW): Medical campus location in Wolfsburg for medical education
• STÄPS - Studentisches Trainingszentrum Ärztlicher Praxis und Simulation
• Lehrhospital
• Alzheimer-Stiftung
• UMG add on

Products and services

• Inpatient Hospital Services Comprehensive inpatient medical care across 61 clinics, institutes, and departments with 1,600 beds, serving approximately 55,000 inpatients per year. Includes specialized treatment across oncology, cardiovascular medicine, neurosciences, and molecular cell biology.
• Outpatient Clinics and Ambulatory Care Outpatient medical services including consultations, specialized ambulances (Sprechstunden), and ambulatory treatments serving approximately 270,000 outpatients per year.
• Emergency Medicine Services Emergency medical services including the ARDS/ECMO Center for intensive care and specialized emergency treatments for patients in southern Lower Saxony.
• STÄPS Medical Simulation Training Student training center for medical practice and simulation where medical students practice clinical skills using simulated patients (Simulationspersonen) in role-play exercises and OSCE examinations (Objective Structured Clinical Examination).
• Clinical Trials and Research Services Clinical trial services including IT/prozessmanagement, biometry/datenmanagement, project management, vigilance, and on-site management/study secretariats provided through the Studienzentrum (Study Center).
• Medical Degree Programs Comprehensive medical education programs including the Medizincampus Wolfsburg (MCW) campus location for medical education, the Lehrhospital teaching hospital component, and continuing education programs.

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Three partnerships are on record, tiered core.

• Massachusetts Institute of Technology (MIT)coreStrategic or Co-development Partner · 23 June 2026Joint development of expansion microscopy technique that enlarges biological samples by 1,000-fold in each dimension. The technique enables amino acid visualization using conventional light microscopes, making high-resolution protein imaging more accessible without expensive cryo-EM or X-ray crystallography equipment.
• Multi-center Research NetworkcoreStrategic or Co-development Partner · 9 April 2026Multi-center retrospective study on federated CT foundation models for privacy-preserving lymph node metastasis detection in pancreatic cancer, involving multiple institutions to improve diagnostic accuracy while protecting patient data.
• German Center for Infection Research (DZIF)coreStrategic or Co-development Partner · 26 January 2026DZIF conducted a phase I clinical trial for the MVA-MERS-S vaccine candidate showing stable and functional immune response persisting at least 24 months after vaccination. Study funded by DZIF and CEPI, published in Nature Communications. This represents a major pandemic preparedness research collaboration.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Universitätsklinikum Freiburg: Multi-specialty German university hospital with a similar combination of oncology, cardiovascular, and neuroscience research priorities. Comparable academic medical center governance model under a public-law structure.
• Universitätsklinikum Köln: Large German university hospital of comparable scale (~1,500 beds) and research breadth. Direct comparable in size, public funding model, and translational research intensity.
• Universitätsklinikum Heidelberg: Major German university hospital with strong translational research and one of the country's leading oncology programs. Closely comparable to UMG in research intensity, NCI-style comprehensive cancer center positioning, and specialty research breadth.
• Universitätsklinikum Essen: German university hospital with notable oncology and transplant programs, comparable in academic structure and multi-specialty care delivery. Relevant reference for UMG's oncology and surgical specialty positioning.
• LMU Klinikum München: Large multi-specialty academic medical center affiliated with Ludwig-Maximilians-Universität. Comparable to UMG in size, multi-specialty depth, and integration of research and patient care under a single university umbrella.
• Universitätsklinikum Tübingen: German university hospital with strong programs in oncology, neuroscience, and infectious disease, overlapping with UMG's research focus areas. Comparable academic medical center structure and translational research orientation.
• Medizinische Hochschule Hannover (MHH): Independent medical university with university hospital of comparable size to UMG (~1,500 beds). Comparable scale, regional role, and research focus areas, including transplantation and immunology.
• Universitätsklinikum Hamburg-Eppendorf (UKE): Comparable-scale German university hospital (~1,700+ beds, ~10,000 staff) with research strengths in oncology, neuroscience, and cardiovascular medicine. Directly comparable operating model, bed count, and research portfolio to UMG.
• Charité – Universitätsmedizin Berlin: Largest German university hospital with a comparable three-pillar model of research, teaching, and patient care. Operates at significantly larger scale (~3,000 beds) and is the most direct reference peer for UMG's academic medical center operating model.

Regional players

• Universitätsspital Basel: Comparable Swiss university hospital with multi-specialty academic medical center structure and translational research orientation. Operates in a different national healthcare system (Swiss DRG) but is structurally and functionally analogous to UMG.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/universitaetsmedizin-goettingen

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University Medicine Göttingen